Explore the words cloud of the Bio2Skin project. It provides you a very rough idea of what is the project "Bio2Skin" about.
The following table provides information about the project.
Coordinator |
BESTHEALT H4U UNIPESSOAL LDA
Organization address contact info |
Coordinator Country | Portugal [PT] |
Total cost | 71˙429 € |
EC max contribution | 50˙000 € (70%) |
Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
Code Call | H2020-SMEInst-2018-2020-1 |
Funding Scheme | SME-1 |
Starting year | 2019 |
Duration (year-month-day) | from 2019-08-01 to 2020-01-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | BESTHEALT H4U UNIPESSOAL LDA | PT (BRAGA) | coordinator | 50˙000.00 |
Bio2Skin is a revolutionary new generation of medical-grade adhesives with a wide range of uses in the application of medical devices and wound dressings. This disruptive and unique adhesive will provide a welcome alternative to the current glues used in the application of devices and dressings to the skin which tend to provoke severe skin problems.
Currently available adhesives are viscous materials made of synthetic chemicals that fill the skin irregularities, to augment the contact area. When peeled off, they provoke dermatitis, which is caused by the removal of a large amount of epidermis cells. Bio2Skin allows the development of a line of products that can provide effective protection against Medical Adhesive-Related Skin Injury (MARSI).
Bio2Skin is based on our unique research on glue-less naturally occurring chemicals results in adhesion to surfaces materially different. Our novel material results from the combination of highly biocompatible chemically-modified polymers that display excellent adhesion properties equivalent or better to current chemical glue-based adhesives.
As our product is based with nature in mind, Bio2Skin binds to the natural features of skin offering good adhesion properties without damaging the skin either during use or upon removal, reducing or even eliminating the skin damage caused by the continuous use of current adhesives.
Small-scale pre-clinical tests at the Centre for Nanotechnology and Smart Materials (CeNTI Portugal) so far have been extremely promising, and we believe we can make a significant impact in the medical adhesive market which is projected to reach €10 billion by 2019.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIO2SKIN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "BIO2SKIN" are provided by the European Opendata Portal: CORDIS opendata.
INSIGHTS FOR TALENT ASSESSMENT USING COMPUTER VISION TECHNIQUES FROM NEURO PSYCHOLOGY
Read MoreTracworx is a data analytics tool that allows you to establish bottlenecks in your patient flow, while understanding your efficiencies and ultimately your true capacity.
Read MoreMANUBACK, the smart garment for operator protection in the field of Manual Handling of Goods
Read More